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Abstract
Artificial intelligence (AI) is growing exponentially in various fields, including medicine. This paper
reviews the pertinent aspects of AI in obstetrics and gynecology (OB/GYN) and how these can be applied
to improve patient outcomes and reduce the healthcare costs and workload for clinicians.
Herein, we will address current AI uses in OB/GYN, and the use of AI as a tool to interpret fetal heart rate
(FHR) and cardiotocography (CTG) to aid in the detection of preterm labor, pregnancy complications,
and review discrepancies in its interpretation between clinicians to reduce maternal and infant
morbidity and mortality. AI systems can be used as tools to create algorithms identifying asymptomatic
women with short cervical length who are at risk of preterm birth. Additionally, the benefits of using the
vast data capacity of AI storage can assist in determining the risk factors for preterm labor using
multiomics and extensive genomic data. In the field of gynecological surgery, the use of augmented
reality helps surgeons detect vital structures, thus decreasing complications, reducing operative time,
and helping surgeons in training to practice in a realistic setting. Using three-dimensional (3D) printers
can provide materials that mimic real tissues and also helps trainees to practice on a realistic model.
Furthermore, 3D imaging allows better depth perception than its two-dimensional (2D) counterpart,
allowing the surgeon to create preoperative plans according to tissue depth and dimensions. Although
AI has some limitations, this new technology can improve the prognosis and management of patients,
reduce healthcare costs, and help OB/GYN practitioners to reduce their workload and increase their
efficiency and accuracy by incorporating AI systems into their daily practice.
AI has the potential to guide practitioners in decision-making, reaching a diagnosis, and improving case
management. It can reduce healthcare costs by decreasing medical errors and providing more
dependable predictions. AI systems can accurately provide information on the large array of patients in
clinical settings, although more robust data is required.
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Introduction And Background
Artificial intelligence (AI) is a type of digital computer system that parallels the way the human brain
processes information. AI is organized in a similar way that neurons in the brain are arranged, with their
multiple neural nodes, and so are referred to as neural networks [1-2]. The rise of AI has led to the
subsequent development of artificial neural networks (ANN), which consist of a dependable
mathematical system that can interpret multifactorial data [3-5]. These neurons are connected via
multiple synapses and send the data to each other back and forth, and by doing so, come up with the
most probable answer. Making these multiple connections enables computers to mimic cognitive
functions, such as the reasoning process, to identify the most probable answer to a problem. This
complex algorithm AI software is now utilized in medicine to analyze large amounts of data, which can
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assist in disease prevention, diagnosing, and monitoring patients [2]. In recent years, there has been an
enormous rise in the global growth of artificial intelligence in healthcare systems. According to
statistics, expenditure on AI is expected to increase from $2.1 billion to $36.1 billion by 2025 [3].
Artificial intelligence requires training and collaboration between partners for it to become a success in
healthcare. One example is IBM's Watson for Oncology (IBM Corp., Armonk, NY), a well-known AI
technology that has received appraisal from customers, which is mostly used for prescription
information extraction from various drug databases and medical journals [4].
Overall, AI can aid practitioners in decision-making and will help clinicians to make more self-assured
decisions. However, it is important to keep in mind that it is not a substitute for clinical
experience [3]. The third leading cause of death in the United States (US) is medical errors, and AI can
potentially help reduce them by improving accuracy in interpretation and decreasing the workload that
can lead to details being overlooked [5]. In this article, we introduce different types of AI, their potential
applications, associated research, benefits, limitations, and the future of AI, as well as how it can benefit
the field of obstetrics and gynecology (OB/GYN).

Review
Fetal heart monitoring and pregnancy surveillance
Fetal heart rate (FHR) monitoring helps the healthcare provider to monitor the fetus and diagnose
associated high-risk complications. It also gives a qualitative and quantitative overview of baseline FHR,
variability, acceleration, deceleration, uterine contraction intensity, and FHR pattern changes [6].
Currently, AI is used to monitor the FHR rate during labor via analyzing cardiotocographs and
estimating possible outcomes. As Desai stated in his study, the benefits of its incorporation in obstetrics,
specifically antepartum monitoring, would be advantageous [2]. This technology would help to decrease
the discrepancies between different obstetricians interpreting intrapartum monitoring, thus providing a
more reliable and replicable output for each analysis, and ultimately reducing perinatal and maternal
complications and morbidity. Artificial intelligence systems can also provide supporting evidence in
cases of unpredictable poor outcomes that can potentially result in litigation. One of the examples of
where AI was tested in cardiotocography (CTG) analysis was published in 2018 where the CAFE
(Computer-Aided Fetal Evaluator) studied the possibility of an AI system being able to interpret CTG
data [2]. The results concluded that the AI system read the information at a similar level as the experts in
the field and was also able to detect errors. Some limitations in this study were disagreements between
specialists when interpreting some data, mostly in interpreting variations, which led to an inability to
conclude if the error in interpretation arose from a problem in the system or in obtaining agreement
between experts in the field [7]. This was an obstacle in proving that the system is optimum and
confirming its precision. More robust research is required to enhance flexibility in data interpretation.
CTG technology arose 50 years ago, and frequent differences between specialists urge for a system that
decreases error and unifies interpretation while analyzing CTG. The Computerised Interpretation of
Fetal Heart Rate During Labour (INFANT) study protocol is a large trial currently evaluating the ability of
AI interpretation of CTG during labor to assist practitioners in deciding the best management on an
individual basis [8]. The goal is to make FHR reading more reliable, to aid the physician in interpreting
and decision-making, and decrease the burden of work by making it more efficient. Perinatal asphyxia is
a significant problem worldwide, and by creating an efficient way to monitor FHR, it would improve care
and decrease poor outcomes. Thus, an alarm monitor that warns of potential fetal distress can guide the
practitioner to act in a timely matter and perform intrapartum interventions when necessary. It can also
provide reassurance and avoid unnecessary treatment in those women where fetal distress is not
observed.
System 8000 is a computer system that analyzes the antenatal FHR [8-9]. It monitors changes in FHR and
detects amplitudes associated with hypoxemia by detecting decelerations and changes in variability.
Currently, a decrease in variation is the most dependable index of fetal deterioration, but unfortunately,
there is significant observer variation in interpreting this data. The introduction of AI can decrease this
difference between readers, which can lead to a more reliable interpretation of variation, decrease
unnecessary interventions, and expedite the delivery if necessary.
A study was done by Kazantsev et al. urges the development of new technologies that can address the
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issue of maternal and infant mortality [10]. The researchers in this study believed that AI technology
could be used for outpatient care in the form of home monitors that can adequately provide surveillance
of high-risk patients. This technology, in conjunction with telemedicine, can potentially aid in earlier
detection of potential complications and reassure the clinician and the patient that a safe system of
monitoring is being used, even if at an outside clinic or hospital care. It also provides a warning system
that informs the patient of dangerous FHR readings and signals them to notify the physician to decide on
further care according to the in-home AI analysis. In this study, they used neural network recognition
algorithms that could provide a solution to interpretation discrepancies between specialists. It also
mentioned that outpatient monitoring is readily accessible because most homes have access to the
Internet and smartphones. The insertion of AI into Doppler ultrasound has proven to be cost-effective.
The system was also able to exclude readings of uncertain meaning, such as pseudo accelerations and
pseudo decelerations that occur due to intense fetal movement, thus not falsely alarming the patient of
possible fetal endangerment. The downside of the study was that the proposed method was only tested
in one subject, and even though it proved successful, a larger study is needed to replicate its results and
validate this intervention. The possibility of guiding decision-making and management using
telecommunications, combined with in-home pregnancy monitoring, can prove beneficial in the early
detection of pregnancy complications and decrease maternal and infant mortality [8-10].

Gestational diabetes mellitus
Current screening for gestational diabetes mellitus (GDM) is costly and a burden for pregnant women. AI
can assist in finding ways to replace the current standard. Current screening guidelines, according to the
United States Preventive Services Task Force, consist of a 50 g of oral glucose challenge test performed
after 24-week gestation, followed by a second diagnostic test. They found insufficient evidence to screen
before 24-week gestation [11]. Screening for GDM is important to prevent complications, such as
hypoglycemia in the neonate, large for gestational age, and an increased number of cesarean births,
amongst others. GDM also results in more expensive outcomes due to increased cesarean deliveries,
which could be decreased if a more convenient screening test was available. Polak and Mendyk created a
study to evaluate the use of an AI calculator to screen for GDM that would be more cost-efficient and less
inconvenient for the patient than current guidelines [12]. They proposed the use of an online calculator
that a physician and patient can use for screening. The calculator was based on an artificial neuronal
network (ANN) which was adapted to a Java applet and published online [12]. The model they used to
create the AI system is called multi-layer perceptrons, which can send information back and forth, hence
its denomination as an algorithm-back propagation (BP). Risk factors, such as high blood pressure,
hyperlipidemia, smoking, weight, low-fat diet, and ethnicity, are used to create the calculator. The
authors concluded that despite AI having lower-efficacy than the standard screening test, the current
ANN model on the website will continue to progress and learn as it continues to be exposed to more
cases, with the finality of eventually helping to lower health costs [13]. An additional benefit is that it is
user-friendly, which makes it practical for daily use.

Preterm labor
Innovative research by Singh et al. studied the combination of AI and amniotic fluid (AF) proteomics and
metabolomics, in conjunction or independently with imaging, demographic, and clinical factors, to
predict perinatal outcomes in asymptomatic women with short cervix length [14]. The type of AI they
used was called deep learning (DL). This subtype of AI can operate with a larger amount of data because
it has a greater number of neural networks, which makes it ideal for biological system studies involving
multiomics. Currently, the short cervical length is the strongest risk factor for prematurity; however,
many women with this condition carry their pregnancy to term. Many centers now incorporate
amniocentesis in these women to evaluate additional factors that might put them at risk, such as
inflammation and infectious processes. The AF of the subjects was additionally studied for omics, such
as metabolomics, to shed light on potential new biomarkers that might be involved in preterm birth.
This can improve the accuracy and predictive value of women at risk of poor outcomes. It can also help
physicians stratify those patients at risk of preterm birth better than the current risk factors, such as
short cervical length and prior preterm birth delivery [15]. In this way, physicians can use this tool to
guide their management, such as observation alone, or suggesting cervical cerclage and or antenatal
steroids if deemed necessary. A shortcoming of the study was the small size of the group. The study
concluded that DL was a superior tool when it came to the prediction of perinatal outcome in
asymptomatic women with short cervix length and that further studies are needed to analyze AF omics
and its relationship to premature shortening of the cervix to help guide management in these patients.
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A study done by Idowu et al. emphasized the importance of using AI technology to decrease expenses
generated by inaccurate detection of preterm labor leading to unnecessary hospitalizations and
procedures, and in the meantime, expedite treatment in those who are in true labor to prevent
hazardous consequences for the baby and the mother [16]. In this study, they used electrohysterography
(EHG) signals and used three distinct machine learning algorithms to classify these signals to help them
identify true labor and accurately diagnose preterm labor. They concluded that the random forest
algorithm performed the most efficiently of the three machines tested, as it was able to handle a larger
amount of data, was relatively accurate, and had a robust learning capacity which resulted in an accuracy
of 97% in predicting preterm labor.

Parturition
The onset of labor can lead to complications when this occurs before or after the ideal time frame, such
as preterm or post-term pregnancy. To get a better understanding, Mason et al. used gene array profiling
of myometrial events during guinea pig pregnancy to achieve a better comprehension of the molecular
mechanisms that regulate labor [17]. In this study, they used AI technology to develop diagrams
composed of gene circuits which helped them in extracting the pertinent information about myometrial
activation from a considerable amount of data. However, this study was done in the myometrium of
guinea pigs, and there is yet to be a study illustrating this in humans. Norwitz described AI use to help in
solving issues related to parturition but recommended further studies be done to understand the genes
involved in human parturition and validate these results [18]. Additionally, we need to consider
variables, such as the complications of pregnancy, and how these factors can alter myometrial gene
expression. This study gave an overview in our understanding of how genes that are activated during
labor can potentially lead to effective medical interventions when necessary, thus helping to treat some
of the disorders of parturition, such as preterm labor and post-term pregnancy, and decrease the
associated perinatal morbidity and mortality involved with these complications.
An example of a novel program that can aid with the task of understanding how gene expression in the
myometrium is programmed is the MetaCore program [19]. It consists of a knowledge database and
software that can analyze data and gene lists. Its limitations are that it needs prior knowledge about the
problem or a predefined algorithm. Reasons for preterm or post-term labor are multifactorial, and not all
factors are known or well understood [17-19]. Nonetheless, other programs that do not require prior
knowledge or utilize a defined algorithm, such as neural networks, can overcome these aforementioned
limitations. MetaCore is also able to analyze large amounts of data, such as genomes and their variables,
and analyze it nonlinearly. A disadvantage is that it requires a significant amount of time and research
because all simulated computer predictions need to be tested in humans to confirm their accuracy and
practicability.

In vitro fertilization
A study done by Guh et al. used data mining and AI to create a computer algorithm that can help predict
pregnancy using in vitro fertilization (IVF) [20]. Data mining (DM) uses AI in conjunction with advanced
statistics to discover patterns in large databases. DM extracts the information of interest and is also able
to find new key elements that might influence the outcome, thus increasing the amount of data that can
be utilized [13, 21]. Finding new trends that influence success rates for IVF are important for the patient
and the clinician to have realistic outcome expectations. To help clinicians predict pregnancy success
rates, they created a hybrid intelligence model that used DM to integrate genetic algorithm-based and
decision tree learning techniques that extracted information from the IVF patient records. They found
that this model not only helped predict outcomes but suggested modified IVF treatment according to
individual patient characteristics. A downside of the study is that the model they created used data from
only one IVF center. However, if the centers united to share information, their pooled data could
significantly be expanded to represent a wider population with increased accuracy. Other studies suggest
using ANN systems to predict IVF outcomes by using a learning vector quantizer which allows
generalization and standard parameters for enhanced predictive power [20]. Another aspect of IVF and
AI is the possibility of identifying the most viable oocytes and embryos. An AI system used by Manna et
al. suggested combining AI to extract texture descriptors from an image (local binary pattern) and
assembling it by using an ANN [22]. These results proved to be above average when compared to current
methods and could help to select the best possible oocytes or embryos noninvasively and objectively.
Furthermore, they highlight the advantages of this technology in selecting the most viable embryos,
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even in countries where legislation precludes embryo selection by sex.

Cancer screening
Neural network models are being used to deliver prognoses in patients with ovarian cancer. Ovarian
cancer is a catchall for heterogeneous neoplasm, and there is a great variation in histology and inpatient
presentation, such as existing tumor stages. In a report done by Enshaei et al., their results demonstrated
that ANN was able to predict survival with a 97% accuracy [23]. The AI systems they developed have the
potential of providing an accurate prognosis. Similarly, Norwitz et al. have created an AI software that
can predict prognosis in patients with ovarian cancer more precisely than current methods [18, 23]. It
can also predict the most effective treatment according to the diagnosis of each patient. Long-term
survival rates for advanced ovarian cancer are poor; thus, more targeted therapies are needed.
Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute have been using AI to
manipulate large amounts of micro ribonucleic acid (RNA) data to develop models that can potentially
diagnose early ovarian cancer [23]. Currently, no screening for ovarian cancer exists despite it being a
common gynecological cancer. Thus, most cases are diagnosed in advanced stages, leading to a high
five-year mortality rate. The AI neural network was able to keep up with the complex interactions
between micro RNA and accurately identified almost 100% of abnormalities that represented ovarian
cancer, as opposed to an ultrasound screening test that was able to identify abnormal results less than
5% of the time. This non-invasive testing consists of measuring micro RNAs from a serum sample, which
can be paramount for the future management of ovarian cancer.
To identify patients at risk of more aggressive tumors, a newly developed AI system has been created to
scan ovarian cancer cells; this system can help identify irregularly-shaped nuclei that correlate with
tumor aggressiveness [19, 23]. Scanning by an AI system can be incorporated in routine biopsies to
identify these risk factors related to DNA instability and choose therapies accordingly. Evasion of the
immune system has been identified in the misshapen nuclei in aggressive ovarian cells, indicating that
there can be a response to immune-targeted treatments, such as onco-immunotherapy.
AI has recently been incorporated into oncology through commercial applications that use the algorithm
to match patient data with current clinical trials nationwide and respective investigational drugs per
patient [24-26]. IBM's Watson for Oncology uses AI in conjunction with patient data to help guide cancer
management, which has proven efficient for breast cancer patients [27].
Furthermore, AI has outperformed human experts in interpreting cervical pre-cancer images [26]. The
current screening consists of visual inspection of the specimen collected during a Papanicolaou (PAP)
smear and using acetic acid to visualize whitening in the tissue which would be indicative of disease.
Despite its convenience and low cost, it lacks accuracy. AI deep learning algorithms can gather a large
number of images related to cervical cancer screening and appropriately identify diseased tissue. It also
ensures that the test is convenient, accurate, and cost-effective, unlike the current method. Minimal
training is required, and the results are immediate; thus, patients can receive treatment in the same
visit [24-26].

Gynecological surgery
In surgery, the application of physical AI has been utilized more than virtual AI. Virtual AI uses
established patient factors, repetitive patterns, and treatment algorithms to predict the outcome, as
opposed to the surgical field, which has many independent variables. Some of these variables are the
consistency of different tissues, the skills of each surgeon, the changes that are done in the surgical field
while operating, and unique differences between patients and their pathology; ultimately, these unique
factors make it challenging to create an algorithm [27].
Areas in which AI has assisted gynecological surgery include those related to imaging and spatial
awareness. AI can aid the surgeon by providing better imaging before and during surgery. The creation of
three-dimensional printing (3DP) that replicates the surgical site is far superior to its two-dimensional
(2D) counterpart, as it represents a more precise version of the actual model [28-29]. This allows a more
accurate preoperative plan, hence diminishing errors in the operating room. 3DP can also provide
different materials that can resemble the tissues that would be encountered, thus providing realistic

2020 Iftikhar et al. Cureus 12(2): e7124. DOI 10.7759/cureus.7124

5 of 9

practice for trainees and unprecedented preoperative planning [29]. Ultimately, a 3DP image helps to
navigate the surgical field and increase awareness of the area involved, thereby protecting its
surrounding structures. This has proved useful in one case report for deep infiltrating endometriosis
(DIE) [27, 29]. A 3DP model was derived from preoperative magnetic resonance imaging (MRI) and then
later compared retrospectively with the surgical findings. The surgeons agreed the 3DP image assisted in
planning to calculate the depth, extent, and involvement of the adjacent structures and how to proceed
accordingly. These models can potentially serve as adjuncts for preoperative planning where depth and
spatial relationships are challenging to analyze by the standard 2D image alone.
AI has also helped decrease operative time and accuracy, which subsequently decreases operative
complications [27]. This has been done via the utilization of augmented reality. Augmented reality
consists of a computer that can reconstruct objects taken from the real-world and enhance them
virtually to create a more informative visual image [30-31]. One review of augmented reality in surgery
summarizes some of the shortcomings of this technology, such as increased cost, concern for a latency of
the system, and that the head-mounted display is heavy and impractical for long surgeries [32].
Furthermore, augmented reality might cause nausea and vomiting due to “simulator sickness,” which
would be less than ideal during surgery. Augmented reality might also demonstrate too much
information and increase clutter, thus distracting the surgeon from the task on hand, and would be most
helpful in an immobile structure so that mobile organs (like the uterus) are not ideal for this technology.
Despite certain disadvantages, the authors of the review concluded that, overall, there are positive
benefits to augmented reality, such as increased precision, safety, and a time reduction in performing
procedures [32]. Nonetheless, further studies and improvements still need to be done to take full
advantage of its potential benefits [31].
Other examples of computer systems assisting in surgery are evident in robotics and computer-assisted
platforms. With the help of these platforms, the possibility to opt for a minimally invasive route during
surgery becomes feasible and can help reduce invasive surgeries, their associated risks, and reduce
operative times. Some robotics can even decrease tremors to promote accuracy [27]. Additionally, the
introduction of instruments, such as 3D laparoscopic surgery which aids in-depth visibility, has the
potential to provide better surgical outcomes [32].
AI has aided in enhancing spatial awareness, cautioning surgeons if certain vessels or structures of
importance are concealed, identifying them in a timely matter, and being able to protect vital structures.
An example is isolating the ureters during gynecological surgery. A study was done using an endoscope
system based on AI using algorithms to estimate the depth and location of the ureters, which proved to
enhance accuracy and safety [33].

Discussion
Machine learning can significantly improve healthcare; however, the downsides of machine AI need to
be considered. Ethical dilemmas, such as the potential of human biases when creating computer
algorithms, need to be addressed [34]. Health care predictions can vary by race, genetics, and gender
amongst other variations, and failure to take these into account might over or underestimate patient
risk factors. As stated in the review by Ho et al. concerning AI analytics in healthcare, it will become the
responsibility of the clinician to ensure that AI algorithms are developed and applied appropriately [35].
It is imperative that healthcare continues to operate by ethically defined guidelines to sustain
trustworthiness and that medicine continues to prioritize the good of the patient. AI continues to be
promising since it can decrease healthcare costs and reduce clinician workload as it collaborates in
decision-making.
AI will become more intertwined in clinical practice, and there are machine learning instruments that no
longer require the revision of a clinician to interpret their results, such as in the case of the IDX-DR AI
device (IDx Technologies Inc., Coralville, IA), which detects mild diabetic retinopathy [36]. Since this
software does not require interpretation by a specialist, more primary care physicians can use it in their
practice, potentially decreasing the workload for specialists, and making the interpretation available for
all types of clinicians. This can potentially be applied to obstetrics regarding the interpretation of FHR
and CTG interpretations.
There are instances where AI-based computer-aided design (CAD) has led to decreased diagnostic
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precision in the interpretation of mammography [37]. AI alone was shown to be superior to a single
radiologist in detecting breast cancer. However, in practice, an individual radiologist reviews these
images, and due to bias, might dismiss CAD suggestions [35]. Nonetheless, when two specialists review
the image, it is most likely to undergo additional testing if the readers disagree with each other. Thus, in
this study, it was unclear if AI was cost-effective when compared to interpretation by two radiologists.
Additional disadvantages are that AI-based CAD cannot explain the reasoning behind a decision. Thus,
in case of a misinterpretation by the software, it is difficult to determine if the manufacturer or the
radiologist that interpreted the data is at fault. Creating agencies that can develop standards that
validate and ensure product quality and accuracy need to be established. Additionally, the algorithms
created need to deliver under a broad range of settings that can adequately mirror real-world conditions
to which they are being applied clinically [38]. Real-world settings are easier to mimic using a larger
amount of data which can be obtained by accessing patient records. However, patient confidentiality
becomes a challenge when retrieving personal information. The development of blockchain systems can
potentially help to keep patient information confidential. This would allow the simultaneous sharing of
data between centers, incorporate it into the AI software, and allow it to continue expanding its array of
records which would lead to improved accuracy [39].
Professionally, clinicians need to familiarize themselves with AI in order to revise it so that the machine
can provide accurate information. Furthermore, it needs to be flexible in adopting new information so
the machine needs to continue learning and changing accordingly. Moreover, the data must be
representative of the population being evaluated in a realistic clinical setting. Despite challenges to AI,
it has the overall potential of revolutionizing patient care by providing a more accurate diagnosis,
alleviating the burden of work for clinicians, decreasing healthcare costs, and providing a baseline
analysis in tests where substantial differences in interpretation between specialists exist. Further
developments in medical AI will continue. Clinicians must embrace them, yet be wary, and when
necessary, recognize its advantages and drawbacks to continue providing the best patient care.

Conclusions
We have discussed the different forms of AI, prior research on AI, its advantages and disadvantages,
potential challenges, and the future of AI application in OB/GYN. Our comprehensive review shows that
AI has a promising future in overcoming diagnostic challenges and improving treatment modalities and
patient outcomes in OB/GYN. Further studies need to be done to decrease bias when creating algorithms
and to increase adaptability in the system, enabling the incorporation of new medical knowledge as new
technology surfaces. Practitioners must also take safety measures to ensure that the analysis is valid and
accurate. AI is not meant to replace practitioners but rather to serve as an adjunct in decision-making.
Ethically, the use of patient records might bridge patient confidentiality since large amounts of data are
required to enable AI systems to have access to the large and varied population statistics which are
encountered in clinical settings, hence providing realistic and accurate predictions.

Additional Information
Disclosures
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the
following: Payment/services info: All authors have declared that no financial support was received
from any organization for the submitted work. Financial relationships: All authors have declared that
they have no financial relationships at present or within the previous three years with any organizations
that might have an interest in the submitted work. Other relationships: All authors have declared that
there are no other relationships or activities that could appear to have influenced the submitted work.

Acknowledgements
I would like to express my gratitude to Dr. Arnold P. Wendroff for his expert advice and continuous
support.

References
1.

It’s a No Brainer: An Introduction to Neural Networks . (2019). Accessed: January 26, 2020:
http://community.alteryx.com/t5/Data-Science-Blog/It-s-a-No-Brainer-An-Introduction-to-Neural-

2020 Iftikhar et al. Cureus 12(2): e7124. DOI 10.7759/cureus.7124

7 of 9

2.
3.
4.
5.
6.
7.

8.

9.
10.

11.
12.

13.
14.

15.
16.

17.

18.
19.
20.

21.
22.
23.
24.
25.
26.
27.

Networks/ba-p/300479.
Desai GS: Artificial intelligence: the future of obstetrics and gynecology. J Obstet Gynaecol India. 2018,
68:326-27. 10.1007/s13224-018-1118-4
KLAS: Artificial Intelligence Success Requires Partnership, Training . (2019). Accessed: January 26, 2020:
http://healthitanalytics.com/news/klas-artificial-intelligence-success-requires-partnership-training .
Artificial Intelligence in Healthcare Spending to Hit $36B. (2020). Accessed: January 26, 2020:
http://healthitanalytics.com/news/artificial-intelligence-in-healthcare-spending-to-hit-36b .
Makary MA, Daniel M: Medical error-the third leading cause of death in the US . BMJ. 2016, 353:i2139.
10.1136/bmj.i2139
Computer-assisted Fetal Monitoring - Obstetrics (SURFAO-Obst) . (2019). Accessed: January 28, 2020:
http://clinicaltrials.gov/ct2/show/NCT03857126.
Guijarro-Berdiñas B, Alonso-Betanzos A: Empirical evaluation of a hybrid intelligent monitoring system
using different measures of effectiveness. Artif Intell Med. 2002, 24:71-96. 10.1016/S09333657(01)00091-4
Brocklehurst P; INFANT Collaborative Group: A study of an intelligent system to support decision
making in the management of labour using the cardiotocograph - the INFANT study protocol. BMC
Pregnancy Childbirth. 2016, 16:10. 10.1186/s12884-015-0780-0
Dawes GS, Moulden M, Redman CWG: System 8000: computerized antenatal FHR analysis. J Perinat
Med. 1991, 19:47-51. 10.1515/jpme.1991.19.1-2.47
Kazantsev A, Ponomareva J, Kazantsev P, Digilov R, Huang P: Development of e-health network for inhome pregnancy surveillance based on artificial intelligence. Proc 2012 IEEE-EMBS Interntl Conf
Biomedical Health Informatics. 2012, 82:82-84. 10.1109/BHI.2012.6211511
Polak S, Mendyk A: Artificial intelligence technology as a tool for initial GDM screening . Expert Syst
Appl. 2004, 26:455-460. 10.1016/j.eswa.2003.10.005
Final Recommendation Statement: Gestational Diabetes Mellitus, Screening . (2014). Accessed: January
26, 2020:
http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/gestationaldiabetes-mellitus....
Andrew LB, Isaac SK: Big data and machine learning in health care . JAMA. 2018, 319:1317-18.
10.1001/jama.2017.18391
Bahado‐Singh RO, Sonek J, McKenna D, et al.: Artificial intelligence and amniotic fluid multiomics:
prediction of perinatal outcome in asymptomatic women with short cervix. Ultrasound Obstet Gynecol.
2019, 54:110-18. 10.1002/uog.20168
Lee KS, Ahn KH: Artificial Neural Network analysis of spontaneous preterm labor and birth and its
major determinants. J Korean Med Sci. 2019, 34:e128. 10.3346/jkms.2019.34.e128
Idowu IO, Fergus P, Hussain A, Dobbins C, Khalaf M, Casana Eslava RV, Keight R: Artificial Intelligence
for detecting preterm uterine activity in gynecology and obstetric care. 2015 IEEE International
Conference on Computer and Information Technology; Ubiquitous Computing and Communications;
Dependable, Autonomic and Secure Computing; Pervasive Intelligence and Computing. 2015, 215:21520. 10.1109/CIT/IUCC/DASC/PICOM.2015.31
Mason CW, Swaan PW, Weiner CP: Identification of interactive gene networks: a novel approach in gene
array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol. 2006, 194:151323. 10.1016/j.ajog.2005.12.044
Norwitz ER: Artificial intelligence: can computers help solve the puzzle of parturition? . Am J Obstet
Gynecol. 2006, 194:1510-12. 10.1016/j.ajog.2005.12.054
MetaCore and Genomic Analysis Tools . (2019). Accessed: January 26, 2020:
http://www.nihlibrary.nih.gov/resources/tools/metacore-and-genomic-analysis-tools.
Guh RS, Wu TCJ, Weng SP: Integrating genetic algorithm and decision tree learning for assistance in
predicting in vitro fertilization outcomes. Expert Syst Appl. 2011, 38:4437-49.
10.1016/j.eswa.2010.09.112
Siristatidis C, Pouliakis A, Chrelias C, Kassanos D: Artificial intelligence in IVF: a need . Syst Biol Reprod
Med. 2011, 57:179-85. 10.3109/19396368.2011.558607
Manna C, Nanni L, Lumini A, Pappalardo S: Artificial intelligence techniques for embryo and oocyte
classification. Reprod Biomed Online. 2013, 26:42-49. 10.1016/j.rbmo.2012.09.015
Enshaei A, Robson CN, Edmondson RJ: Artificial intelligence systems as prognostic and predictive tools
in ovarian cancer. Ann Surg Oncol. 2015, 22:3970-75. 10.1245/s10434-015-4475-6
AI Behind Potential Blood Test for Ovarian Cancer . (2017). Accessed: January 26, 2020:
http://www.mdlinx.com/oncology/article/1230..
Kann BH, Thompson R, Thomas CR Jr, Dicker A, Aneja S: Artificial intelligence in oncology: current
applications and future directions. Oncology (Williston Park). 2019, 33:46-53.
Using Artificial Intelligence to Detect Cervical Cancer . (2019). Accessed: January 26, 2020:
http://directorsblog.nih.gov/2019/01/17/using-artificial-intelligence-to-detect-cervical-cancer/..
Moawad G, Tyan P, Louie M: Artificial intelligence and augmented reality in gynecology . Curr Opin

2020 Iftikhar et al. Cureus 12(2): e7124. DOI 10.7759/cureus.7124

8 of 9

28.

29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.

Obstet Gynecol. 2019, 31:345-48. 10.1097/GCO.0000000000000559
Waran V, Narayanan V, Karuppiah R, Owen SL, Aziz T: Utility of multimaterial 3D printers in creating
models with pathological entities to enhance the training experience of neurosurgeons. J Neurosurg.
2014, 120:489-92. 10.3171/2013.11.JNS131066
Ajao MO, Clark NV, Kelil T, Cohen SL, Einarsson JI: Case report: three-dimensional printed model for
deep infiltrating endometriosis. J Minim Invasive Gynecol. 2017, 24:1239-42. 10.1016/j.jmig.2017.06.006
Marescaux J, Rubino F, Arenas M, Mutter D, Soler L: Augmented-reality-assisted laparoscopic
adrenalectomy. JAMA. 2004, 292:2211-15. 10.1001/jama.292.18.2214-c
Vávra P, Roman J, Zonča P, et al.: Recent development of augmented reality in surgery: a review . J
Healthc Eng. 2017 , 2017:4574172. 10.1155/2017/4574172
Dirie NI, Wang Q, Wang S: Two-dimensional versus three-dimensional laparoscopic systems in urology:
a systematic review and meta-analysis. J Endourol. 2018, 32:781-90. 10.1089/end.2018.0411
Song E, Yu F, Liu H, Cheng N, Li Y, Jin L, Hung CC: A novel endoscope system for position detection and
depth estimation of the ureter. J Med Syst. 2016, 40:266. 10.1007/s10916-016-0607-1
Char DS, Shah NH, Magnus D: Implementing machine learning in health care—addressing ethical
challenges. N Engl J Med. 2018, 378:981-83. 10.1056/NEJMp1714229
Ho CWL, Soon D, Caals K, Kapur J: Governance of automated image analysis and artificial intelligence
analytics in healthcare. Clin Radiol. 2019, 74:329-37. 10.1016/j.crad.2019.02.005
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye
problems. (2019). Accessed: January 26, 2020: http://2019. Accessed October 12, 2019.
Freer TW, Ulissey MJ: Screening mammography with computer-aided detection: prospective study of
12,860 patients in a community breast center. Radiology. 2001, 220:745-50. 10.1148/radiol.2203001282
US FDA Approaches to Artificial Intelligence. (2018). Accessed: January 26, 2020:
http://www.natlawreview.com/article/us-fda-approaches-to-artificial-intelligence.
Maxmen A: AI researchers embrace Bitcoin technology to share medical data . Nature. 2018, 555:293-94.
10.1038/d41586-018-02641-7

2020 Iftikhar et al. Cureus 12(2): e7124. DOI 10.7759/cureus.7124

9 of 9

